Diligence memo · auto-generated · as of July 2, 2026
Sora Neuroscience, Inc.
Sora Neuroscience, Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Sora Neuroscience, Inc. operates in Other Health Care, based in Minneapolis.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sora Neuroscience, Inc. has raised $3.4M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.0M on 2021-08-23.
Most recent recorded round closed around 2023-10-16.
Valuation (modeled)modeled
Provath models Sora Neuroscience, Inc. at approximately $8.6M (range $1.2M–$28M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.72× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Within the normal band (72% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 2.7 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 1.9× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 57% of Other Health Care peers (5377 compared).
Modeled value ranks above 31% of those peers.
Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.